TURINABOL Depot

Description

The new TURINABOL DEPOT prolonged release tablets utilize a brand new developed triple acetate modified delivery system for enhanced drug-like delivery of the anabolic compound into the body.

The current methods of drug delivery exhibit specific problems, for examptermany drugs’ potency and therapeutic effects are limited or otherwise reduced because of the partial degradation that occurs before they reach a desired target in the body.

The goal of all sophisticated drug delivery systems, therefore, is to deploy the medication intact to specifically targeted parts of the body through a medium that can control the therapy’s administration by means of either a physiological or chemical trigger. To achieve this goal, researchers are turning to advances in the worlds of micro- and nanotechnology. During the past decade, polymeric microspheres, polymer micelles, and hydrogel-type materials have all been shown to be effective in enhancing drug targeting specificity, lowering systemic drug toxicity, improving treatment absorption rates, and providing protection for Pharmaceuticals against biochemical degradation.

The TURINABOL DEPOT prolonged release tablets coating is polymer and polysaccharides based. TURINABOL DEPOT prolonged release tablets are designed to bypass liver and gastric degradation to remain intact until the active pharmaceutical ingredient (API) reaches the cell signaling receptors.

Once ingested, this time-release formula delivers treatment continuously, rather than providing relief of symptoms, protection from adverse events or increase in strength and muscle solely when necessary. By incorporating the dose of 24 hours into 1 prolonged release tablet from which the drug is slowly released, peaks of high plasma concentration and troughs of low plasma concentration can be prevented.

This helps avoid the side effects associated with high concentrations and the lack of activity associated with low concentrations-giving better overall performance. TURINABOL DEPOT is a slower acting steroid. The usage of TURINABOL DEPOT will lead to weight, strength and muscle mass increases.

TURINABOL DEPOT also does not create risk for estrogenic side effects, so there is limited water retention or risk for gynecomastia. Each tablet contains 20mg 4-Chlorodehydromethyltestosterone. TURINABOL DEPOT is 17-alpha alkylated which means it can be toxic to the liver. TURINABOL DEPOT can also lower the clotting ability of blood. Negative side effects are rare but can occur from cycles that are too long or high in dosage. Shutting off of the natural testosterone production and testicular tumors are both side effects of such extreme cycles, although extremely rare.